Literature DB >> 33293834

Developing a Kinase-Specific Target Selection Method Using a Structure-Based Machine Learning Approach.

Arina Afanasyeva1, Chioko Nagao1,2, Kenji Mizuguchi1,2.   

Abstract

INTRODUCTION: Despite recent advances in the drug discovery field, developing selective kinase inhibitors remains a complicated issue for a number of reasons, one of which is that there are striking structural similarities in the ATP-binding pockets of kinases.
OBJECTIVE: To address this problem, we have designed a machine learning model utilizing various structure-based and energy-based descriptors to better characterize protein-ligand interactions.
METHODS: In this work, we use a dataset of 104 human kinases with available PDB structures and experimental activity data against 1202 small-molecule compounds from the PubChem BioAssay dataset "Navigating the Kinome". We propose structure-based interaction descriptors to build activity predicting machine learning model. RESULTS AND DISCUSSION: We report a ligand-oriented computational method for accurate kinase target prioritizing. Our method shows high accuracy compared to similar structure-based activity prediction methods, and more importantly shows the same prediction accuracy when tested on the special set of structurally remote compounds, showing that it is unbiased to ligand structural similarity in the training set data. We hope that our approach will be useful for the development of novel highly selective kinase inhibitors.
© 2020 Afanasyeva et al.

Entities:  

Keywords:  activity prediction; docking; interaction descriptors; kinase; machine learning

Year:  2020        PMID: 33293834      PMCID: PMC7719317          DOI: 10.2147/AABC.S278900

Source DB:  PubMed          Journal:  Adv Appl Bioinform Chem        ISSN: 1178-6949


  36 in total

1.  Predicting drug-target interactions from chemical and genomic kernels using Bayesian matrix factorization.

Authors:  Mehmet Gönen
Journal:  Bioinformatics       Date:  2012-06-23       Impact factor: 6.937

Review 2.  Cutaneous side-effects of kinase inhibitors and blocking antibodies.

Authors:  Caroline Robert; Jean-Charles Soria; Alain Spatz; Axel Le Cesne; David Malka; Patricia Pautier; Janine Wechsler; Catherine Lhomme; Bernard Escudier; Valérie Boige; Jean-Pierre Armand; Thierry Le Chevalier
Journal:  Lancet Oncol       Date:  2005-07       Impact factor: 41.316

3.  A general method applicable to the search for similarities in the amino acid sequence of two proteins.

Authors:  S B Needleman; C D Wunsch
Journal:  J Mol Biol       Date:  1970-03       Impact factor: 5.469

4.  Hierarchical clustering schemes.

Authors:  S C Johnson
Journal:  Psychometrika       Date:  1967-09       Impact factor: 2.500

5.  Demystifying Multitask Deep Neural Networks for Quantitative Structure-Activity Relationships.

Authors:  Yuting Xu; Junshui Ma; Andy Liaw; Robert P Sheridan; Vladimir Svetnik
Journal:  J Chem Inf Model       Date:  2017-10-02       Impact factor: 4.956

Review 6.  PI3K/Akt/mTOR pathway as a target for cancer therapy.

Authors:  Daniel Morgensztern; Howard L McLeod
Journal:  Anticancer Drugs       Date:  2005-09       Impact factor: 2.248

7.  Inhibitors of cyclin-dependent kinases as anti-cancer therapeutics.

Authors:  P M Fischer; D P Lane
Journal:  Curr Med Chem       Date:  2000-12       Impact factor: 4.530

8.  Directory of useful decoys, enhanced (DUD-E): better ligands and decoys for better benchmarking.

Authors:  Michael M Mysinger; Michael Carchia; John J Irwin; Brian K Shoichet
Journal:  J Med Chem       Date:  2012-07-05       Impact factor: 7.446

9.  ACPYPE - AnteChamber PYthon Parser interfacE.

Authors:  Alan W Sousa da Silva; Wim F Vranken
Journal:  BMC Res Notes       Date:  2012-07-23

10.  Development and evaluation of a deep learning model for protein-ligand binding affinity prediction.

Authors:  Marta M Stepniewska-Dziubinska; Piotr Zielenkiewicz; Pawel Siedlecki
Journal:  Bioinformatics       Date:  2018-11-01       Impact factor: 6.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.